Skip to main content
HR 3391 115th Congress House Health Administrative law and regulatory procedures Alternative treatments Department of Health and Human Services Drug safety, medical device, and laboratory regulation Drug therapy Drug trafficking and controlled substances Food and Drug Administration (FDA) Health personnel Licensing and registrations Medical research Research administration and funding

Medical Marijuana Research Act of 2017

Introduced: November 6, 2017 Introduced by: Harris, Andy Republican · Maryland See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 6, 2017
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Jul 28, 2017
Referred to the Subcommittee on Health.
Jul 25, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 25, 2017
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Medical Marijuana Research Act of 2017

This bill amends the Controlled Substances Act to establish a new, separate registration process to facilitate research with marijuana for medical purposes. The Drug Enforcement Administration must register: (1) practitioners to conduct medical marijuana research, and (2) manufacturers and distributors to supply marijuana for such research.

The Department of Health and Human Services must continue to produce marijuana through the National Institute on Drug Abuse Drug Supply Program and offer to sell immature plants and seeds to researchers until manufacturers and distributors can provide a sufficient supply of marijuana for medical research.

What's happening now September 6, 2017

Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

 Related & companion bills 2
  • S 780 Related bill Responsibly Addressing the Marijuana Policy Gap Act of 2017
  • HR 1824 Related bill Responsibly Addressing the Marijuana Policy Gap Act of 2017
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 6
All 6 Democratic 2 Republican 3
R
Guthrie, Brett
Kentucky · Jul 24, 2018
 R
Amodei, Mark E.
Nevada · Feb 2, 2018
Curbelo, Carlos
· Nov 6, 2017
 D
Norton, Eleanor Holmes
District of Columbia · Nov 6, 2017
 R
Griffith, H. Morgan
Virginia · Jul 25, 2017
 D
Lofgren, Zoe
California · Jul 25, 2017
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 3391: Medical Marijuana Research Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-HR-3391/
MLA
"H.R. 3391: Medical Marijuana Research Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-3391/.
Bluebook (legal)
H.R. 3391, 115th Cong. (2026), https://openamerica.io/bill/115-HR-3391/.
Markdown link
[H.R. 3391: Medical Marijuana Research Act of 2017](https://openamerica.io/bill/115-HR-3391/)
Report a problem